While CETP inhibitors have shown promise, they also present challenges. Clinical trials of some CETP inhibitors have been discontinued due to adverse effects or lack of efficacy in reducing cardiovascular events. The complexity of lipid metabolism and the role of CETP in various physiological processes make it challenging to develop safe and effective CETP inhibitors.
